157 related articles for article (PubMed ID: 15515587)
1. Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease.
von Euler H; Einarsson R; Olsson U; Lagerstedt AS; Eriksson S
J Vet Intern Med; 2004; 18(5):696-702. PubMed ID: 15515587
[TBL] [Abstract][Full Text] [Related]
2. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
von Euler HP; Ohrvik AB; Eriksson SK
Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
[TBL] [Abstract][Full Text] [Related]
3. Plasma thymidine kinase activity in dogs with lymphoma and leukemia.
Nakamura N; Momoi Y; Watari T; Yoshino T; Tsujimoto H; Hasegawa A
J Vet Med Sci; 1997 Oct; 59(10):957-60. PubMed ID: 9362053
[TBL] [Abstract][Full Text] [Related]
4. Serum thymidine kinase activity in clinically healthy and diseased horses: a potential marker for lymphoma.
Larsdotter S; Nostell K; von Euler H
Vet J; 2015 Aug; 205(2):313-6. PubMed ID: 25744802
[TBL] [Abstract][Full Text] [Related]
5. Serum thymidine kinase activity in clinically healthy and diseased cats: a potential biomarker for lymphoma.
Taylor SS; Dodkin S; Papasouliotis K; Evans H; Graham PA; Belshaw Z; Westberg S; von Euler HP
J Feline Med Surg; 2013 Feb; 15(2):142-7. PubMed ID: 23076596
[TBL] [Abstract][Full Text] [Related]
6. Thymidine kinase assay in canine lymphoma.
Elliott JW; Cripps P; Blackwood L
Vet Comp Oncol; 2013 Mar; 11(1):1-13. PubMed ID: 22236202
[TBL] [Abstract][Full Text] [Related]
7. Serum thymidine kinase activity: an alternative to histologic markers of cellular proliferation in canine lymphoma.
Madewell BR
J Vet Intern Med; 2004; 18(5):595-6. PubMed ID: 15515571
[TBL] [Abstract][Full Text] [Related]
8. Serum thymidine kinase activity as a useful marker for bovine leukosis.
Sakamoto L; Ohbayashi T; Matsumoto K; Kobayashi Y; Inokuma H
J Vet Diagn Invest; 2009 Nov; 21(6):871-4. PubMed ID: 19901293
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serum thymidine kinase 1 activity as a biomarker for treatment effectiveness and prediction of relapse in dogs with non-Hodgkin lymphoma.
Boyé P; Floch F; Serres F; Geeraert K; Clerson P; Siomboing X; Bergqvist M; Sack G; Tierny D
J Vet Intern Med; 2019 Jul; 33(4):1728-1739. PubMed ID: 31129922
[TBL] [Abstract][Full Text] [Related]
10. A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma.
Sharif H; von Euler H; Westberg S; He E; Wang L; Eriksson S
Vet J; 2012 Oct; 194(1):40-7. PubMed ID: 22516918
[TBL] [Abstract][Full Text] [Related]
11. Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity--evaluation of a new, fully automated non-radiometric assay.
Von Euler HP; Rivera P; Aronsson AC; Bengtsson C; Hansson LO; Eriksson SK
Int J Oncol; 2009 Feb; 34(2):505-10. PubMed ID: 19148486
[TBL] [Abstract][Full Text] [Related]
12. A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.
Jagarlamudi KK; Moreau L; Westberg S; Rönnberg H; Eriksson S
PLoS One; 2015; 10(9):e0137871. PubMed ID: 26366881
[TBL] [Abstract][Full Text] [Related]
13. Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity.
He Q; Zhang P; Zou L; Li H; Wang X; Zhou S; Fornander T; Skog S
Oncol Rep; 2005 Oct; 14(4):1013-9. PubMed ID: 16142366
[TBL] [Abstract][Full Text] [Related]
14. Utility of a multiple serum biomarker test to monitor remission status and relapse in dogs with lymphoma undergoing treatment with chemotherapy.
Alexandrakis I; Tuli R; Ractliffe SC; Tappin SW; Foale RD; Roos A; Slater KJ
Vet Comp Oncol; 2017 Mar; 15(1):6-17. PubMed ID: 25319380
[TBL] [Abstract][Full Text] [Related]
15. Serum thymidine kinase as a prognostic indicator for patients with multiple myeloma: results from the MRC (UK) V trial.
Brown RD; Joshua DE; Nelson M; Gibson J; Dunn J; MacLennan IC
Br J Haematol; 1993 Jun; 84(2):238-41. PubMed ID: 8398824
[TBL] [Abstract][Full Text] [Related]
16. [The prognostic significance of serum thymidine kinase in the myelodysplastic syndrome].
Aul C; Germing U; Gattermann N; Söhngen D; Heyll A
Dtsch Med Wochenschr; 1996 Sep; 121(37):1113-8. PubMed ID: 8925725
[TBL] [Abstract][Full Text] [Related]
17. Serum thymidine kinase as a marker of disease activity in patients with multiple myeloma.
Brown RD; Joshua DE; Ioannidis RA; Kronenberg H
Aust N Z J Med; 1989 Jun; 19(3):226-32. PubMed ID: 2528340
[TBL] [Abstract][Full Text] [Related]
18. Serum alpha 1-acid glycoprotein concentrations before and after relapse in dogs with lymphoma treated with doxorubicin.
Hahn KA; Freeman KP; Barnhill MA; Stephen EL
J Am Vet Med Assoc; 1999 Apr; 214(7):1023-5. PubMed ID: 10200796
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Serum Thymidine Kinase Activity as Novel Monitoring, Prognostic, and Predictive Biomarker in Pancreatic Cancer.
Felix K; Hinz U; Dobiasch S; Hackert T; Bergmann F; Neumüller M; Gronowitz S; Bergqvist M; Strobel O
Pancreas; 2018 Jan; 47(1):72-79. PubMed ID: 29189449
[TBL] [Abstract][Full Text] [Related]
20. Serum amyloid A is not a marker for relapse of multicentric lymphoma in dogs.
Merlo A; Rezende BC; Franchini ML; Monteiro PR; Lucas SR
Vet Clin Pathol; 2008 Mar; 37(1):79-85. PubMed ID: 18366549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]